Fluorescence lifetime imaging of activatable target specific molecular probes

Contrast Media and Molecular Imaging

Volumn 5, Issue 1, 2010, Pages 1-8

  Alford, Raphael ^a,c   Ogawa, Mikako ^a   Hassan, Moinuddin ^b   Gandjbakhche, Amir H ^b   Choyke, Peter L ^a   Kobayashi, Hisataka ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activatable fluorescence probe; Cancer; Fluorescence lifetime; Molecular imaging; Near infrared

Indexed keywords

ALEXA FLUOR750 ESTER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTER; TRASTUZUMAB; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONJUGATE; ENDOSOME; EXPOSURE; FLUORESCENCE IMAGING; FLUORESCENCE LIFETIME IMAGING; IMMUNOREACTIVITY; INTERNALIZATION; MOLECULAR IMAGING; MOLECULAR PROBE; MOUSE; NONHUMAN; PH; PHOTOCHEMICAL QUENCHING; PRIORITY JOURNAL; TARGET CELL; TEMPERATURE; TUMOR;

ANIMALS; ANTIBODIES, MONOCLONAL; DIAGNOSTIC IMAGING; ENDOCYTOSIS; FLUORESCENT DYES; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; MOLECULAR PROBES; NEOPLASM TRANSPLANTATION; NIH 3T3 CELLS; SPECTROMETRY, FLUORESCENCE; SUCCINIMIDES; TIME FACTORS;

EID: 77449091337     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.360     Document Type: Article

References (29)

1. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003; 17: 545-580.
2. Ntziachristos V. Fluorescence molecular imaging. Annu Rev Biomed Eng 2006; 8: 1-33.
3. Weissleder R. Molecular imaging in cancer. Science 2006; 312: 1168-1171.
4. Ogawa M, Kosaka N, Longmire MR, Urano Y, Choyke PL, Kobayashi H. Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases. Mol Pharm 2009; 6: 386-395.
5. Ogawa M, Regino CA, Choyke PL, Kobayashi H. In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies. Mol Cancer Ther 2009; 8: 232-239.
6. Ogawa M, Kosaka N, Choyke PL, Kobayashi H. In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. Cancer Res 2009; 69: 1268-1272.
7. Hoffman RM. The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer 2005; 5: 796-806.
8. Hoffman RM, Yang M. Subcellular imaging in the live mouse. Nat Protocols 2006; 1: 775-782.
9. Hoffman RM, Yang M. Color-coded fluorescence imaging of tumor-host interactions. Nat Protocols 2006; 1: 928-935.
10. Kishimoto H, Zhao M, Hayashi K, Urata Y, Tanaka N, Fujiwara T, Penman S, Hoffman RM. In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation. Proc Natl Acad Sci USA 2009; 106: 14514-14517.
11. van Munster EB, Gadella TW. Fluorescence lifetime imaging microscopy (FLIM). Adv Biochem Eng Biotechnol 2005; 95: 143-175.
12. Hassan M, Riley J, Chernomordik V, Smith P, Pursley R, Lee SB, Capala J, Gandjbakhche AH. Fluorescence lifetime imaging system for in vivo studies. Mol Imag 2007; 6: 229-236.
13. Clegg RM, Holub O, Gohlke C. Fluorescence lifetime-resolved imaging: measuring lifetimes in an image. Meth Enzymol 2003; 360: 509-542.
14. Gannot I, Ron I, Hekmat F, Chernomordik V, Gandjbakhche A. Functional optical detection based on pH dependent fluorescence lifetime. Lasers Surg Med 2004; 35: 342-348.
15. Schaferling M, Wu M, Wolfbeis OS. Time-resolved fluorescent imaging of glucose. J Fluoresc 2004; 14: 561-568.
16. Lakowicz JR, Szmacinski H, Nowaczyk K, Berndt KW, Johnson M. Fluorescence lifetime imaging. Anal Biochem 1992; 202: 316-330.
17. Hanson KM, Behne MJ, Barry NP, Mauro TM, Gratton E, Clegg RM. Two-photon fluorescence lifetime imaging of the skin stratum corneum pH gradient. Biophys J 2002; 83: 1682-1690.
18. Hille C, Berg M, Bressel L, Munzke D, Primus P, Lohmannsroben HG, Dosche C. Time-domain fluorescence lifetime imaging for intracellular pH sensing in living tissues. Anal Bioanal Chem 2008; 391: 1871-1879.
19. Lakowicz JR, Szmacinski H, Nowaczyk K, Lederer WJ, Kirby MS, Johnson ML. Fluorescence lifetime imaging of intracellular calcium in COS cells using Quin-2. Cell Calcium 1994; 15: 7-27.
20. Lakowicz JR, Szmacinski H, Nowaczyk K, Johnson ML. Fluorescence lifetime imaging of calcium using Quin-2. Cell Calcium 1992; 13: 131-147.
21. Borst JW, Hink MA, van Hoek A, Visser AJ. Effects of refractive index and viscosity on fluorescence and anisotropy decays of enhanced cyan and yellow fluorescent proteins. J Fluoresc 2005; 15: 153-160.
22. Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003; 7: 626-634.
23. Harari D, Yarden Y. Molecular mechanisms underlying ErbB2/ HER2 action in breast cancer. Oncogene 2000; 19: 6102-6114.
24. Murphy RF, Powers S, Cantor CR. Endosome pH measured in single cells by dual fluorescence flow cytometry: rapid acidification of insulin to pH 6. J Cell Biol 1998; 98: 1757-1762.
25. Hama Y, Urano Y, Koyama Y, Bernardo M, Choyke PL, Kobayashi H. A comparison of the emission efficiency of four common green fluorescence dyes after internalization into cancer cells. Bioconjug Chem 2006; 17: 1426-1431.
26. Barrett T, Koyama Y, Hama Y, Ravizzini G, Shin IS, Jang BS, Paik CH, Urano Y, Choyke PL, Kobayashi H. In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies. Clin Cancer Res 2007; 13: 6639-6648.
27. Longmire M, Kosaka N, Ogawa M, Choyke PL, Kobayashi H. Multicolor in vivo targeted imaging to guide real-time surgery of HER2-positive micrometastases in a two-tumor coincident model of ovarian cancer. Cancer Sci 2009; 100: 1099-1104.
28. Elias DR, Thorek DL, Chen AK, Czupryna J, Tsourkas A. In vivo imaging of cancer biomarkers using activatable molecular probes. Cancer Biomark 2008; 4: 287-305.
29. Ogawa M, Kosaka N, Choyke PL, Kobayashi H. Tumor-specific detection of an optically targeted antibody combined with a quencher-conjugated neutravidin 'quencher-chaser': a dual 'quench and chase' strategy to improve target to nontarget ratios for molecular imaging of cancer. Bioconjug Chem 2009; 20: 147-154.